Liquidia Common Stock share price logo

Liquidia Common Stock

NASDAQ: LQDA

Mid Cap

$68.01

-3.79

(-5.28%)

as on

Liquidia Common Stock Stock Performance

as on June 17, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $66.55
    $73.22
    downward going graph

    2.15%

    Downside

    7.66%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $11.85
    $73.22
    downward going graph

    82.58%

    Downside

    7.66%

    Upside

    downward going graph

Liquidia Common Stock share price movements today

Previous Close
$71.80
Open
$72.16
Volume
2.2M
Day's Low - High
$66.55 - $73.22
52 Week Low - High
$11.85 - $73.22

Liquidia Common Stock Historical Returns

1 Month Return
+ 19.46 %
3 Month Return
+ 84.51 %
1 Year Return
+ 400.44 %
3 Year Return
+ 688.06 %
5 Year Return
0 %

Liquidia Common Stock Stock Fundamentals & Key Indicators

Check Liquidia Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.4B

EPS (TTM)

3.48

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

422.35

Industry PE ratio

16.479

PEG Ratio

0

EBITDA

46.6M

Revenue (TTM)

288.1M

Profit Margin

7.74%

Return On Equity TTM

28.18%

Liquidia Common Stock Stock Valuation

Track how Liquidia Common Stock P/E has moved over time to understand its valuation trends.

Liquidia Common Stock in the last 5 years

  • Overview

  • Trends

Lowest (-34.30x)

December 31, 2025

Industry (16.48x)

June 17, 2026

Today (422.35x)

June 17, 2026

Highest (-5.46x)

June 30, 2022

LowHigh

Today’s Price to Earnings Ratio: 422.35x

Liquidia Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Liquidia Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Liquidia Common Stock image
Liquidia Common Stock
BUY$6.4BNA422.357.74%NA
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$23.3B200.57%20.2840.62%NA
Viatris Inc. image
Viatris Inc.
HOLD$19.0B9.34%NA-2.04%2.91%
Haleon plc (ADR) image
Haleon plc (ADR)
BUY$40.0BNA18.1415.11%2.13%
ZOETIS INC. image
ZOETIS INC.
BUY$33.5B-57.45%13.1128.04%2.55%
See all

Stock Returns calculator for Liquidia Common Stock Stock including INR - Dollar returns

The Liquidia Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Liquidia Common Stock investment value today

Current value as on today

₹5,51,185

Returns

₹4,51,185

(+451.18%)

Returns from Liquidia Common Stock Stock

₹4,00,442 (+400.44%)

Dollar Impact

₹50,743 (+50.74%)

Analyst Recommendation on Liquidia Common Stock Stock

Based on 13 analysts

BUY

84.62%

Buy

7.69%

Hold

7.69%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Liquidia Common Stock. Average target price of $66.12

Liquidia Common Stock Share Price Target

Get share price movements and forecasts by analysts on Liquidia Common Stock.

What analysts predicted

-2.86%DOWNSIDE

Target Price

$66.12

Current Price

$68.01

Analyzed by

13 Analysts

Target

$66.12

Liquidia Common Stock target price $66.12, a slight downside of -2.86% compared to current price of $68.01. According to 13 analysts rating.

Indian Investors' Interest in Liquidia Common Stock Stock

Search interest for Liquidia Common Stock Stock has increased by 203% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:203% versus previous 30 day period

Liquidia Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
4
2
3
4
2
3
8
54
92
132
Gross Profit
3
1
2
2
1
1
7
51
84
120
Operating Income
-26
-28
-27
-29
-36
-35
-37
1
19
61
EBITDA
-24
-37
-24
-19
-33
-33
-35
3
21
63
Interest Expense
1
2
2
2
4
4
5
6
6
6
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-27
-40
-27
-23
-38
-38
-41
-3
14
56
Income Tax Expense
-2
0
-
-
-
-
-
-
-
3
Net Income
-27
-40
-27
-23
-38
-38
-41
-3
14
52
Net Profit Margin
-605.83%
-1377.12%
-763.65%
-520.57%
-1315.36%
-1229.71%
-470.51%
-6.50%
15.82%
39.79%

Liquidia Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
13
7
2
8
0
12
15
17
13
158
Gross Profit
12
6
2
7
0
9
13
14
8
145
Operating Income
-15
-28
-34
-46
-59
-33
-38
-73
-121
-51
EBITDA
-15
-15
-32
-43
-55
-28
-35
-70
-115
-43
Interest Expense
0
13
18
1
0
0
2
6
12
24
Depreciation
-
0
1
2
3
5
3
2
2
1
Income Before Tax
-15
-29
-53
-47
-59
-34
-41
-78
-130
-68
Income Tax Expense
0
13
0
-1
-2
-4
-2
-2
-
-
Net Income
-15
-29
-53
-47
-59
-34
-41
-78
-130
-68
Net Profit Margin
-120.56%
-401.68%
-1962.92%
-589.48%
-8080.11%
-269.03%
-257.39%
-448.89%
-931.65%
-43.53%

Liquidia Common Stock Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-30
-27
-23
-38
-38
-41
-3
14
52
Operating Cash Flow
-24
-22
-25
-20
-30
-39
-9
44
52
Investing Cash Flow
0
-1
-1
-4
0
-1
0
-4
-2
Financing Cash Flow
99
0
98
-2
24
47
-5
-7
-18
Change in Cash
74
-24
71
-27
-6
7
-15
33
32

Liquidia Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-29
-53
-47
-59
-34
-41
-78
-130
-68
Operating Cash Flow
-24
-31
-48
-54
-34
-28
-41
-93
-35
Investing Cash Flow
-2
0
-1
0
0
0
-11
-8
-6
Financing Cash Flow
28
68
66
63
26
64
43
194
59
Change in Cash
1
36
16
9
-7
35
-9
92
14

Global Institutional Holdings in Liquidia Common Stock

Funds
Holdings
Opaleye Management Inc
2.86%
CenterBook Partners LP
1.28%
TANG CAPITAL MANAGEMENT LLC
1.3%
Patient Square Capital
1.18%
The Goldman Sachs Group Inc
0.91%
See all

Liquidia Common Stock News & Key Events

  • img

    Today's Timeline - 12 June

    Fri, 07:45 PM

    -

    Liquidia's 2026 EPS estimates rise to $2.97; shares up 107.7% year-to-date.

Insights on Liquidia Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -41.57M → 52.86M (in $), with an average increase of 424.5% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 2.91M → 132.86M (in $), with an average increase of 45.3% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, LQDA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, LQDA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, LQDA stock has moved up by 19.5%

About Liquidia Common Stock

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil which is in phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). In addition, the company offers PRINT technology which allows to engineer and manufacture uniform drug particles with precise control over the size, three-dimensional geometric shape, and chemical composition of the particles. It has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD; Vectura; The University of North Carolina at Chapel Hill; GlaxoSmithKline; Alcon Inc; and promotion Agreement with Sandoz. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.
OrganisationLiquidia Common Stock
Headquarters419 Davis Drive, Morrisville, NC, United States, 27560
IndustryDrug Manufacturers - Specialty & Generic
CEODr. Roger A. Jeffs Ph.D.
E-voting on sharesClick here to vote

Key Management of Liquidia Common Stock

Name

Title

Mr. Michael Kaseta

COO & CFO

Mr. Michael Post

Senior Vice President of Marketing

Matt Snow

Senior Vice President of Sales

Dr. Roger A. Jeffs Ph.D.

CEO & Director

Mr. Russell Schundler

General Counsel & Corporate Secretary

Mr. Scott Moomaw

Chief Commercial Officer

Dr. Rajeev Saggar M.D.

Chief Medical Officer

Ms. Dana Boyle

Chief Accounting Officer

Mr. Christian Perez Font

Senior VP, Chief Compliance Officer & Associate General Counsel

Ms. Sarah Krepp SPHR

Chief Human Resources Officer

FAQs

What is Liquidia Common Stock share price today?

Liquidia Common Stock share price today is $68.01 as on at the close of the market. Liquidia Common Stock share today touched a day high of $73.22 and a low of $66.55.

What is the 52 week high and 52 week low for Liquidia Common Stock share?

Liquidia Common Stock share touched a 52 week high of $73.22 on and a 52 week low of $11.85 on . Liquidia Common Stock stock price today i.e. is closed at $68.01,which is 7.12% down from its 52 week high and 473.92% up from its 52 week low.

What is Liquidia Common Stock's market capitalisation today?

Liquidia Common Stock market capitalisation is $0.01T as on .

How to invest in Liquidia Common Stock Stock (LQDA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Liquidia Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Liquidia Common Stock Shares that will get you 0.0221 shares as per Liquidia Common Stock share price of $68.01 per share as on June 17, 2026 at 8:45 am IST.

What is the minimum amount required to buy Liquidia Common Stock Stock (LQDA) from India?

Indian investors can start investing in Liquidia Common Stock (LQDA) shares with as little as ₹94.55 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹945.50 in Liquidia Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Liquidia Common Stock share’s latest price of $68.01 as on June 17, 2026 at 8:45 am IST, you will get 0.1470 shares of Liquidia Common Stock. Learn more about fractional shares .